NCT06289556

Brief Summary

The objective of this clinical study is to validate temperature performance of the noninvasive Masimo INVSENSOR00048.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 23, 2024

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

February 13, 2024

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 4, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 19, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 19, 2025

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

August 25, 2026

Completed
Last Updated

August 25, 2026

Status Verified

July 1, 2026

Enrollment Period

1.3 years

First QC Date

February 13, 2024

Results QC Date

May 15, 2026

Last Update Submit

July 31, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Clinical Performance of Masimo INVSENSOR00048

    The outcome measure is determination of the Masimo INVSENSOR00048 temperature performance by comparing the Clinical Bias and Limits of Agreement (LOA) between the corresponding adjustment mode temperature of the INVSENSOR00048 and reference thermometer in degrees celsius. Clincal Bias is defined as mean difference between output temperatires of a clinical thermometer and a reference clinical thermometer for the intended reference body site with specified limitis of agreement when measured from selected group of subjects . Limits of agreement is defined as the magnitude of a potential disagreement between outputs of two clinical thermometers equal to double the standard deviation of output temperate differences when used on the same human subject .

    Approximately 90 minutes

Study Arms (1)

INVSENSOR00048

EXPERIMENTAL

All subjects are enrolled into this arm and will have temperature measurements obtained.

Device: Masimo INVSENSOR00048

Interventions

Masimo INVSENSOR00048 will be used to collect temperature measurements.

INVSENSOR00048

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Afebrile subjects of all ages, or febrile subjects of all ages who meet the following criteria for screening temperature:
  • sublingual temperature ≥ 37.5°C (99.5°F),
  • rectal temperature ≥ 38.0°C (100.4°F),
  • or axillary temperature ≥ 37.2°C (99.0°F)
  • If subject is \< 18 years old, parents or legally authorized representatives (LAR) have provided informed consent and have signed all necessary related documents

You may not qualify if:

  • Subjects with medical conditions such as inflammation at the measuring site or taking medications e.g. barbiturates, thyroid preparations, antipsychotics, or immunization within prior 7 days, which might skew clinical accuracy validation results such as, per the investigator's judgement
  • Subjects unable to provide informed consent or assent, as appropriate
  • Subjects with conditions at or around site of sensor placement or skin abnormalities affecting the sensor placement area such as psoriasis, eczema, angioma, scar tissue, burn, fungal infection, substantial skin breakdown that would prevent monitoring of physiological parameters during the study
  • Subjects with known allergies to adhesive material used in medical equipment
  • Subjects with medical conditions which, in the judgment of the investigator, renders them inappropriate for participation in this study
  • Excluded at the Principal Investigator's discretion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's Hospital of Orange County

Orange, California, 92868, United States

Location

MeSH Terms

Conditions

Fever

Condition Hierarchy (Ancestors)

Body Temperature ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Chelsea Frank
Organization
Masimo Corporation

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SEQUENTIAL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 13, 2024

First Posted

March 4, 2024

Study Start

January 23, 2024

Primary Completion

May 19, 2025

Study Completion

May 19, 2025

Last Updated

August 25, 2026

Results First Posted

August 25, 2026

Record last verified: 2026-07

Locations